Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that it has initiated patient dosing at the Weill Cornell Medicine Multiple Sclerosis Center in New York City as part of its ongoing Phase 2 clinical trial of intranasal foralumab in patients with non-active Secondary Progressive Multiple Sclerosis (na-SPMS).
Weill Cornell marks the fifth site participating in the trial, joining Yale University, Johns Hopkins University, Brigham and Women’s Hospital, and the University of Massachusetts.
Shares in Challenger Energy Group PLC (AIM:CEG, OTCQB:BSHPF) rose 9% after Stifel reaffirmed its 'buy' rating and 50p target price following the company’s full-year results.
Cash levels came in broadly in line with expectations, reinforcing the view that Challenger remains fully funded for its upcoming work programmes.
Shares in Mirriad Advertising PLC (AIM:MIRI, OTCQX:MMDDF) rose 11% after a regulatory filing revealed that Zeus Investment Management has acquired a significant stake in the company.
According to a disclosure released on Friday, Zeus now holds 1.5 billion shares, representing 8.78% of Mirriad’s voting rights.
Challenger Energy Group PLC (AIM:CEG, OTCQB:BSHPF) has now filed results for what it described as “a transformational year”, and a period in which it recentred its business to focus on offshore Uruguay.
Moreover, it secured a farm-out transaction with tier 1 operator, Chevron, and significantly advanced its prospects.
Vinanz Ltd (LSE:BTC, OTCQB:VINZF), the Bitcoin-focused investment and mining company listed on the London Stock Exchange, has opened a £1m retail share offer as part of a wider push to expand its strategy and shareholder base.
Shares are being offered at 13.75p each through the Winterflood Retail Access Platform, better known as WRAP, with the offer open until 16 June.
Arrow Exploration Corp (TSX-V:AXL, AIM:AXL, OTC:CSTPF) has announced the start of a share buyback programme for up to £2.7 million of shares.
It will be funded out of existing cash, executed by stockbroker Canaccord Genuity and acquired shares will be cancelled.
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF), a biotechnology firm specialising in allergy treatments, is showcasing key research findings at the European Academy of Allergy and Clinical Immunology (EAACI) Congress in Glasgow.
Highlights include promising initial results from its peanut allergy vaccine candidate, which demonstrated safety and a significant reduction in allergic reactions in early human trials.
Atlantic Lithium Ltd (AIM:ALL, OTCQX:ALLIF, ASX:A11) earlier this week outlined updates on its cost reduction initiatives, leadership restructuring, and project developments, as CEO Keith Muller spoke to Proactive.
Livium Ltd earlier this week highlighted its strategy to expand into rare earth element recycling, targeting components such as magnets in wind turbines and electric vehicle motors. CEO Simon Linge joined Proactive's Foaud Haidar to discuss.
Terra Metals Ltd (ASX:TM1, OTC:PNGZF) Ltd has secured A$4 million in strategic funding to expedite the exploration and development of its 100%-owned Dante Project in Western Australia. The capital raising was backed by strategic investors Golden Energy and Resources Pte Ltd (GEAR) and Matthew Latimore, Founder and President of M Resources Pty Ltd, alongside existing major shareholder Tribeca Investment Partners.
The funding will support extensional and resource drilling across the Dante Project, where over 17,000 metres of drilling has defined laterally extensive, reef-style mineralisation over 10 kilometres of strike.
Resolution Minerals Ltd (ASX:RML, OTC:RLMLF) Ltd is finalising its listing on the US OTCQB Market under the ticker symbol RLMLF, in a move aimed at accelerate growth. The decision comes amid growing interest from North American investors and proximity to Perpetua Resources’ critical mineral assets.
The dual listing is expected to bolster Resolution’s profile in the US., attract institutional and retail capital, and potentially pave the way for a future NASDAQ listing. It also enhances accessibility to its Idaho-based Horse Heaven Antimony-Gold-Silver-Tungsten Project, aligning with US policy initiatives to fast-track critical mineral development under the Trump Administration’s FAST-41 framework.